Pharmaceutical & Biotechnology

Yunnan Meng Sheng Pharmaceutical Ltd.

Incorporated in Kunming, Yunnan in 1995, Yunnan Meng Sheng is engaged in the business of research and development, manufacture and sale of pharmaceutical products in the PRC.

The key products include:

Among these products, “Cerebroprotein Hydrolysate Injection” can be used to enhance the growth of brain nerve cells and the recovery of brain functions. Its quality is in par with similar products in the overseas market and ranks top in the PRC market. The feedback of the market has been positive since the launch of these products and its sales volume has been rising tremendously.

Yunnan Meng Sheng will continue to strengthen its research and development capability and enhance its management standard to meet the intense market competition in the PRC.

Founded in Shenzhen in 1992, Shenzhen Xinpeng Biotechnology Company Ltd. is one of the pioneering companies engaging in the research & development, manufacturing and sale of biotech products in the PRC.

Shenzhen Xinpeng is specialised in the research and development, manufacture and sales of biotechnology products With advanced research and development platform in biotechnology products and experienced research and development expertise, Shenzhen Xinpeng has set up its own proprietary R&D centre in Shenzhen and it has cooperated with Changchun Institute of Biological Products, Peking University Health Science Centre, Institute of Virology of Chinese Academy of Preventive Medical Science and Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences on different projects.

Recombinant Human Granulocyte Colony Stimulating Factor Injection (rhG-CSF):
it can help patients to prevent neutropenia and reduce the chance of having infection after chemotherapy.

Recombinant Human Erythropoietin Injection (EPO):
it makes red blood cell grow rapidly for anaemia patient due to chronic renal failure, multiple myeloma, myelodysplasia syndrome and AIDS.